Articles

« go back

Approval Boost for Breast Cancer Pioneer

Endomagnetics, the company developing a portfolio of products to improve the standard of breast cancer management, has achieved certification to an international quality standard.

Endomagnetics’ Quality Management System has been evaluated and certified by BSI as meeting the standards of ISO 13485:2003. This international quality standard specifies the requirements for a comprehensive management system for the design and manufacture of medical devices. In addition, Endomagnetics has met the scope necessary for an upgrade to Annex II of the Medical Device Directive 93/42/EEC, applicable to both its SentiMag®instrument and Sienna+® tracer material. The company’s current product line is ‘CE’ certified.

Endomagnetics was founded to solve cancer staging and healthcare challenges through the application of advanced magnetic sensing technology and nanotechnology. The business is developing a portfolio of medical device products based on a patented ability to detect magnetic materials in the human body with exceptional sensitivity. The technology was originally developed at University College London and the University of Houston. For more information please click here.

 

Source: Business Weekly & Endomagnetics

Comments
No comments yet. Be the first.

Most read articles

ERA-NET EuroNanoMed allocates 8million Euro to European transnational research projects in nanomedicine

EuroNanoMed, a European funding initiative under the ERA-Net scheme of the European Commission...

NanoMedicine Mission to Switzerland Dissemination Event - 6th July 2011

In partnership with One Nucleus and Swiss Embassy London 6th July 2011, Glaziers...